Phytoestrogens/insoluble fibers and colonic estrogen receptor &beta;: Randomized, double-blind, placebo-controlled study

doi:10.3748/wjg.v19.i27.4325

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 27

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5832)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

467

HTML

3176

Figures (1-2)

136

Tables (1-4)

146

Sum=3925

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

876

Download

1031

Sum=1907

Jul 21, 2013 (publication date) through May 2, 2024

Times Cited of This Article

Times Cited (28)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Jul 21, 2013; 19(27): 4325-4333
Published online Jul 21, 2013. doi: 10.3748/wjg.v19.i27.4325

Table 1 Urinary enterolignans (ng/mL) in study groups at different timepoints (mean ± SD)

	Placebo (n = 23)	ADI (n = 27)	P value
ED + ELT0	697.8 ± 963.3	410.3 ± 336.9	0.270
ED + ELT30	472.4 ± 475.5	3300.1 ± 1535.5	< 0.001
ED + ELT60	116.0 ± 235.2	327.5 ± 313.1	< 0.001

ED: Enterodiol; EL: Enterolactone; ADI: Active dietary intervention.

Table 2 T60 colonoscopy: Estrogen receptor-β and estrogen receptor-α expression values in the normal sigmoid mucosa of study groups (mean ± SD)

	Placebo (n = 23)	ADI (n = 27)	P value
ER-β protein	0.768 ± 0.10	0.822 ± 0.08	0.04
ER-β mRNA	0.994 ± 0.99	1.266 ± 1.24	0.10
ER-β protein	0.510 ± 0.11	0.490 ± 0.12	0.50
ER-β mRNA	0.139 ± 0.28	0.230 ± 0.24	0.20
ER-β/ER-α protein	1.571 ± 0.42	1.734 ± 0.20	0.07

ER: Estrogen receptor; ADI: Active dietary intervention.

Table 3 T60 colonoscopy: Labeling index (mean ± SD)

LI	Placebo (n = 23)	ADI (n = 27)	P value
ER-β	37.708 ± 5.31	39.222 ± 2.69	0.06
ER-β	20.416 ± 10.71	16.481 ± 10.67	0.20
ER-β/ER-α	2.437 ± 1.53	6.564 ± 10.04	0.06
TUNEL	31.541 ± 11.54	35.592 ± 14.97	0.07
Caspase-3	29.717 ± 7.98	32.937 ± 13.54	0.10
Ki-67	44.833 ± 10.38	53.923 ± 20.91	0.07

LI: Labeling index; ER: Estrogen receptor; TUNEL: Terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling; ADI: Active dietary intervention.

Table 4 Estrogen receptor-β and estrogen receptor-α, apoptosis and mitosis in non-recurrent patients

Non- recurrent	ER-βprotein	ER-βmRNA	ER-βLI	ER-βprotein	ER-βmRNA	ER-βLI	TUNEL LI	Caspase-3 LI	Ki-67 LI
ADI (median)	0.805	2.278	47.533	0.423	0.295	15.333	43.777	39.444	55.33
SD	0.13¹	1.19²	15.47²	0.06²	0.26	9.76	17.24³	15.6³	20.41
PL (median)	0.773	1.105	34.875	0.532	0.159	16.750	31.375	29.53	45.31
SD	0.13	1.07	16.67	0.11	0.32	8.86	12.93	9.13	11.29

¹P = 0.04,

²P = 0.02,

³P = 0.05 vs placebo group. LI: Labeling index; ER: Estrogen receptor; TUNEL: Terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling; ADI: Active dietary intervention.

Citation: Principi M, Di Leo A, Pricci M, Scavo MP, Guido R, Tanzi S, Piscitelli D, Pisani A, Ierardi E, Comelli MC, Barone M. Phytoestrogens/insoluble fibers and colonic estrogen receptor β: Randomized, double-blind, placebo-controlled study. World J Gastroenterol 2013; 19(27): 4325-4333
URL: https://www.wjgnet.com/1007-9327/full/v19/i27/4325.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i27.4325